Biogen takes another dip into Scribe gene therapy collab with another disease target
Biogen takes another dip into Scribe gene therapy collab with [...]
Patient Square Capital invests $300M to support ‘golden age of therapeutics’ with Enavate Sciences
Patient Square Capital invests $300M to support ‘golden age of [...]
Human testing for Praxis’ lead epilepsy drug held up after FDA clinical hold
Human testing for Praxis’ lead epilepsy drug held up after [...]
AstraZeneca will have to wait a little longer for fruit from $3.5B Ionis ATTR partnership
AstraZeneca will have to wait a little longer for fruit [...]
AbbVie’s cystic fibrosis long-game doesn’t pay off, as Galapagos med fails in triple combo
AbbVie’s cystic fibrosis long-game doesn’t pay off, as Galapagos med [...]
While BMS waits for TYK2 inhibitor’s psoriasis nod, a new path potentially clears in lupus
While BMS waits for TYK2 inhibitor’s psoriasis nod, a new [...]
Genocea’s Atlas no longer holding up sky, as biotech moves for sell off
Genocea’s Atlas no longer holding up sky, as biotech moves [...]
Finch’s C. diff drug cleared of FDA hold, but loose ends leave timing for phase 3 restart unclear
Finch’s C. diff drug cleared of FDA hold, but loose [...]
AstraZeneca kicks off work on 1,500-person R&D center in Kendall Square
AstraZeneca kicks off work on 1,500-person R&D center in Kendall [...]
‘Serious missteps’: All Blue makes case for $773M Zymeworks buyout in wake of flagging stock
‘Serious missteps’: All Blue makes case for $773M Zymeworks buyout [...]